Therapy Areas: Vaccines
Centivax Inc doses first healthy volunteers in Centi-Flu 01 Phase 1A clinical trial
13 February 2026 - Clinical-stage biotechnology company Centivax Inc announced on Thursday that the first participants have been dosed in the company's Phase 1A clinical trial evaluating Centi-Fl...
Delonix Bioworks gets IND clearance for DX-104 in China
9 February 2026 - Clinical-stage biotechnology company Delonix Bioworks announced on Friday that China's National Medical Products Administration (NMPA) has granted Investigational New Drug (IND)...
Valneva and Instituto Butantan launch pilot chikungunya vaccination campaign in Brazil
3 February 2026 - Vaccine company Valneva SE (Nasdaq:VALN) (Euronext Paris:VLA) and biomedical research centre Instituto Butantan said on Tuesday that they have initiated a Pilot Vaccination Strategy ...
European Commission approves GSK's Arexvy for adults aged 18 and over
26 January 2026 - Biopharmaceutical company GSK plc (LSE: GSK) (NYSE: GSK) said the European Commission has approved expanded use of its respiratory syncytial virus vaccine, Arexvy, for adults aged 18...
PhotonPharma adds Dr. William Warren to board
23 January 2026 - PhotonPharma Inc, a developer of autologous cancer immunotherapies, announced on Thursday the appointment of William Warren, Ph.D. to its board of directors.PhotonPharma says that Dr...
Clover Biopharmaceuticals enrols first participants in Phase 2 trial of respiratory combination vaccine candidates
12 January 2026 - Clover Biopharmaceuticals Ltd (HKEX:02197), a China-based commercial-stage biotechnology company, announced on Monday that the first participants have been enrolled in a Phase 2 clin...